Key Segmentation:
By Technology
-
Molecular Diagnostics
-
Immunoassay/Serology
-
Cytogenetics
-
Biochemistry
-
Hematology
-
Microbiology & Culture
-
Others
By Test Type
-
Molecular Tests
-
Immunological Tests
-
Cytogenetic Tests
-
Biochemical Tests
-
Microbiological Tests
-
Others
By Disease Area
-
Oncology
-
Infectious Diseases
-
Rare & Genetic Disorders
-
Cardiovascular Diseases
-
Neurological Disorders
-
Autoimmune Diseases
-
Others
By End User
-
Hospital-Based Laboratories
-
Independent/Reference Laboratories
-
Physician Office Laboratories
-
Academic & Research Institutions
-
Others
By Sample Type
-
Blood
-
Tissue Biopsy
-
Urine
-
Saliva
-
Liquid Biopsy/ctDNA
-
Others
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The Laboratory Developed Tests Market is expected to grow at a CAGR of 7.11% from 2026 to 2035.
The Laboratory Developed Tests Market was valued at USD 14.27 Billion in 2025.
Precision oncology's systematic requirement for comprehensive tumour molecular profiling creating structured NGS-based LDT procurement, and the FDA's LDT Final Rule creating regulatory compliance investment that differentiates established laboratory operators and sustains premium market positioning.
Molecular Diagnostics dominated the Laboratory Developed Tests Market with approximately 26.3% share in 2025, while NGS is the fastest growing sub-segment.
North America dominated the Laboratory Developed Tests Market with approximately 36.4% of revenues in 2025, while Asia Pacific is the fastest-growing region.